RT Journal Article
SR Electronic
T1 Identifiability of infection model parameters early in an epidemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.15.20132217
DO 10.1101/2020.06.15.20132217
A1 Sauer, Timothy
A1 Berry, Tyrus
A1 Ebeigbe, Donald
A1 Norton, Michael M.
A1 Whalen, Andrew
A1 Schiff, Steven J.
YR 2020
UL http://medrxiv.org/content/early/2020/06/17/2020.06.15.20132217.abstract
AB It is known that the parameters in the deterministic and stochastic SEIR epidemic models are structurally identifiable. For example, from knowledge of the infected population time series I(t) during the entire epidemic, the parameters can be successfully estimated. In this article we observe that estimation will fail in practice if only infected case data during the early part of the epidemic (pre-peak) is available. This fact can be explained using a long-known phenomenon called dynamical compensation. We use this concept to derive an unidentifiability manifold in the parameter space of SEIR that consists of parameters indistin-guishable to I(t) early in the epidemic. Thus, identifiability depends on the extent of the system trajectory that is available for observation. Although the existence of the unidentifiability manifold obstructs the ability to exactly determine the parameters, we suggest that it may be useful for uncertainty quantification purposes. A variant of SEIR recently proposed for COVID-19 modeling is also analyzed, and an analogous unidentifiability surface is derived.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a National Institutes of Health Directors Transformative Award (1R01AI145057) and the National Science Foundation (DMS-1723175 and DMS-1854204). MMN was supported in part by the Covid Virus Seed Fund (award 8013) from the Institute for Computational and Data Sciences and the Huck Institute at the Pennsylvania State University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB oversight was necessary in the preparation of this work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data was used in the preparation of this manuscript.